Regenxbio CEO Kenneth Mills' 2018 pay jumps 93% to $4.9M
Regenxbio reports 2018 executive compensation
By ExecPay News
Published: April 11, 2019
Regenxbio reported fiscal year 2018 executive compensation information on April 11, 2019.
In 2018, five Regenxbio executives received on average a compensation package of $2.5M, a 61% increase compared to previous year.
Average pay of disclosed executives at Regenxbio
Kenneth T. Mills, Chief Executive Officer, received $4.9M in total, which increased by 93% compared to 2017. 79% of Mills' compensation, or $3.9M, was in option awards. Mills also received $481K in non-equity incentive plan, $546K in salary, as well as $16K in other compensation.
Vittal Vasista, Chief Financial Officer, received a compensation package of $1.9M, which increased by 64% compared to previous year. 67% of the compensation package, or $1.3M, was in option awards.
Curran Simpson, Chief Technology Officer, earned $1.9M in 2018, a 108% increase compared to previous year.
Stephen Yoo, Chief Medical Officer, received $1.9M in 2018, which increases by 75% compared to 2017.
Olivier Danos, Chief Scientific Officer, earned $1.6M in 2018, a 14% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 11, 2019.